Glass Wall Systems IPO Review: 86% OFS, 19x
A façade contractor is raising ₹428 crore, 86% of it an OFS including a ₹272 crore PE exit, at 19.1x FY26. Structure, cash, and the one listed peer.
By AlphaResearch · 8 Sept 2026 · 7 min read
Issue snapshot
| Company | Glass Wall Systems (India) Ltd — glasswallsystems.in | ||
|---|---|---|---|
| Issue size | ₹428 crore | Price band | ₹172–₹182 |
| Fresh issue | ₹60.00 crore | Offer for sale | ₹368 crore |
| Lot size | 82 shares | Exchange | NSE |
| Bidding | 8–10 Sept 2026 | Listing | 16 Sept 2026 |
Company: Glass Wall Systems (India) Ltd · Mumbai · façade design, fabrication and installation; export product supply to the US and Australia · mainboard IPO, NSE and BSE
AlphaResearch verdict: Neutral at ₹182. The issue clears 2 of our 5 checks; the 86% OFS is what stops it short of a subscribe. Reasoning and the reversal test are in the verdict section below.
Key takeaways
- The book is ₹427.89 crore: ₹60 crore fresh for a glass-processing unit, ₹367.89 crore OFS — 86% of the issue.
- India Business Excellence Fund IIA is selling ₹271.96 crore. Promoters Jawahar and Eshan Hemrajani sell ₹46.05 crore and ₹49.88 crore.
- FY26 revenue from operations was ₹456.97 crore and PAT ₹83.79 crore, after an FY25 revenue dip. Operating cash was positive all three years (₹42.7 / ₹73.0 / ₹73.3 crore).
- At ₹182, post-issue mcap is ₹1,600.42 crore, or 19.1x FY26 — versus Innovators Façade Systems at 15.9x (4 Sep 2026).
- Day 1 (8 Sep, 10:12 IST) printed 0.15x. An unofficial GMP of ₹35 has been quoted — unofficial, unregulated, often wrong.
The deal in one paragraph
Glass Wall Systems designs and installs façades in India and ships product to the US and Australia. The books are clean in one important way: three years of operating cash, almost no debt, and a 64% FY26 revenue recovery. The offer is not a growth raise. ₹60 crore comes in; ₹368 crore goes out, most of it a PE exit. Nineteen times last year’s earnings is a premium to the only listed façade peer, on a year that followed a dip. Our verdict is neutral at ₹182; the reasoning is below.
Data
Issue structure
| Item | Figure | Units |
|---|---|---|
| Total issue | 427.89 | ₹ cr |
| Fresh issue | 60.00 | ₹ cr |
| OFS | 367.89 | ₹ cr |
| of which IBE Fund IIA | 271.96 | ₹ cr |
| Price band | 172–182 | ₹ / share |
| Lot | 82 | shares (₹14,924 at the cap) |
| Promoter group | 64.11 → 55.72 | % |
| Anchor (7 Sep) | 128.37 | ₹ cr |
| Listing (tentative) | 16 Sep 2026 | NSE + BSE |
Source: Chittorgarh; Groww. Fresh proceeds: Vile Bhagad glass-processing unit.
India Business Excellence Fund IIA sells ₹271.96 crore of the OFS; the rest is the Hemrajani promoters.
Financials (restated consolidated, ₹ cr)
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue from operations | 304.34 | 278.33 | 456.97 |
| EBITDA | 54.70 | 73.01 | 105.20 |
| EBITDA margin (on ops) | 18.0% | 26.2% | 23.0% |
| PAT | 20.25 | 57.51 | 83.79 |
| Operating cash flow | 42.72 | 72.95 | 73.25 |
| Net worth | 122.60 | 175.75 | 261.58 |
| Borrowings | 24.85 | 8.46 | 6.68 |
| EPS (₹) | 1.81 | 6.21 | 9.90 |
Units: ₹ crore except EPS and margins. Source: SEBI abridged prospectus. FY24 PAT includes a ₹16.19 crore exceptional item (IPO Watch). Order book prints disagree — ₹981.55 crore (IPO Watch) vs ₹846 crore (broker note) — so I do not use either in the title.
Operating cash was positive in all three years; FY25 revenue dipped before the FY26 recovery.
Valuation at the upper band
| Metric | At ₹182 |
|---|---|
| Post-issue mcap | ₹1,600.42 cr |
| P/E post-issue FY26 | 19.1x |
| P/E on FY25 PAT | 27.8x |
| P/B on NAV ₹30.91 | 5.89x |
| Innovators Façade P/E (4 Sep 2026) | 15.9x |
| Innovators FY26 PAT | ₹13.56 cr |
Units: rupees crore and times. Source: Chittorgarh; IPO Watch; Trade Brains. One peer, smaller and less profitable — useful as a floor, not a clone.
Innovators Façade earned ₹13.56 crore in FY26 — a smaller, less profitable business, so a floor rather than a clone.
Subscription and unofficial GMP
Day 1, 8 Sep 2026, 10:12 IST (Groww): overall 0.15x, retail 0.22x, NII 0.18x, QIB 0.00x. Anchors already put in ₹128.37 crore on 7 Sep. Livemint quoted an unofficial GMP of +₹35 versus ₹182. Grey-market prints are informal and often wrong.
Risks
- 86% OFS, including a ₹272 crore PE sale.
- One thin peer at 16x; 19x is a premium on a recovery year.
- FY25 revenue decline; FY26 needs another year to look like a run-rate.
- Customer / supplier concentration and overseas jobs (Trade Brains).
- Contingent liabilities ₹33.41 crore as of 31 Mar 2026 (IPO Watch).
- Façade EPC is tied to the real-estate cycle.
AlphaResearch verdict
Neutral at ₹182. Clears 2 of 5 checks (business, numbers). Price is partial. The OFS fails.
- Business · ClearsReal façade franchise; India plus US and Australia export supply; borrowings down to ₹6.68 crore.
- Numbers · ClearsOperating cash positive in all three years (₹42.72 / ₹72.95 / ₹73.25 crore); PAT ₹20.25 → ₹83.79 crore.
- Price · Partial19.1x FY26 vs Innovators Façade 15.9x; 27.8x on FY25 PAT.
- Structure · Fails₹367.89 crore of ₹427.89 crore (86%) is an OFS, ₹271.96 crore of it a PE exit.
- Red flags · FailsOne thin listed peer; FY25 revenue decline; contingent liabilities ₹33.41 crore; real-estate cycle exposure.
Why: three years of positive operating cash and near-zero debt are real and rare in construction-adjacent IPOs. Against that, ₹368 crore of the ₹428 crore leaves with a private-equity seller, and 19x last year’s earnings is a premium to the only listed façade peer on a recovery year. Nothing here says pay a premium; nothing here says the business is broken. No edge either way at ₹182.
What flips this verdict: to Subscribe — a live price near the peer multiple on FY26, or two post-listing quarters of revenue at or above ₹110 crore with operating cash still positive. To Avoid — the first reported half with negative operating cash.
Dates: allotment 11 Sep; listing tentatively 16 Sep 2026.
A companion video is planned; it will quote only numbers that appear here or in docs/ipo_analysis/glass_wall_systems.md.
Disclaimer
AlphaResearch is not a SEBI-registered investment adviser or research analyst. The verdict in this article is AlphaResearch’s independent opinion, formed from publicly available information as of the date shown; it is not personalised investment advice and does not consider your financial situation, goals or risk tolerance. Figures are taken from the sources listed below and may contain errors; verify them in the original filings. Investing in securities involves risk, including loss of principal. Consult a SEBI-registered adviser before acting on anything here.
Position disclosure: none.
Sources
- SEBI abridged prospectus, restated financials (accessed 8 Sept 2026)
- Chittorgarh, issue table, OFS sellers, objects (accessed 8 Sept 2026)
- Groww, Day-1 subscription 10:12 IST (accessed 8 Sept 2026)
- IPO Watch, P/E and exceptional item (accessed 8 Sept 2026)
- Trade Brains, peer Innovators Façade (accessed 8 Sept 2026)
- Livemint, unofficial GMP +₹35 (accessed 8 Sept 2026)